Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
复制标题
DOI:
10.1371/journal.pone.0096396
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Sagen J
中科院分区:
文献类型:
--
作者:
Hama AT;Germano P;Varghese MS;Cravatt BF;Milne GT;Pearson JP;Sagen J
Amelioration of neuropathic spinal cord injury (SCI) pain is a clinical challenge. Increasing the endocannabinoid anandamide and other fatty acid amides (FAA) by blocking fatty acid amide hydrolase (FAAH) has been shown to be antinociceptive in a number of animal models of chronic pain. However, an antinociceptive effect of blocking FAAH has yet to be demonstrated in a rat model of neuropathic SCI pain. Four weeks following a SCI, rats developed significantly decreased hind paw withdrawal thresholds, indicative of below-level cutaneous hypersensitivity. A group of SCI rats were systemically treated (i.p.) with either the selective FAAH inhibitor URB597 or vehicle twice daily for seven days. A separate group of SCI rats received a single dose (p.o.) of either the selective FAAH inhibitor PF-3845 or vehicle. Following behavioral testing, levels of the FAA N-arachidonoylethanolamide, N-oleoyl ethanolamide and N-palmitoyl ethanolamide were quantified in brain and spinal cord from SCI rats. Four weeks following SCI, FAA levels were markedly reduced in spinal cord tissue. Although systemic treatment with URB597 significantly increased CNS FAA levels, no antinociceptive effect was observed. A significant elevation of CNS FAA levels was also observed following oral PF-3845 treatment, but only a modest antinociceptive effect was observed. Increasing CNS FAA levels alone does not lead to robust amelioration of below-level neuropathic SCI pain. Perhaps utilizing FAAH inhibition in conjunction with other analgesic mechanisms could be an effective analgesic therapy.
登录
查看更多内容
影响因子:
4.7
作者:
Gwak, Young S.;Hulsebosch, Claire E.
通讯作者:
Hulsebosch, Claire E.
DOI:
10.1523/jneurosci.2428-10.2010
发表时间:
2010-11-03
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Bedi SS;Yang Q;Crook RJ;Du J;Wu Z;Fishman HM;Grill RJ;Carlton SM;Walters ET
通讯作者:
Walters ET
DOI:
10.1124/jpet.111.180257
发表时间:
2011-07-01
影响因子:
3.5
作者:
Ahn, Kay;Smith, Sarah E.;Cravatt, Benjamin F.
通讯作者:
Cravatt, Benjamin F.
影响因子:
4.2
作者:
Christensen, MD;Hulsebosch, CE
通讯作者:
Hulsebosch, CE
影响因子:
4.5
作者:
Ahmed, Mostafa M.;Rajpal, Sharad;Resnick, Daniel K.
通讯作者:
Resnick, Daniel K.